Novel cancer therapy extends lives of terminally ill dogs, shows potential for use in human patients

Researchers from the Department of Biochemistry and NUS Centre for Cancer Research (N2CR), at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have been pioneering a treatment using stem cell precision engineering technology, to deliver drugs directly to tumor sites in dogs and cats with late-stage cancer and no treatment options available.

This post was originally published on this site

Skip The Dishes Referral Code - Consult a Lawyer Online in a variety of legal subjects